Advertisement
Document › Details
Arix Bioscience plc. (4/23/18). "Press Release: Annual Results 2017". London.
Organisation | Arix Bioscience plc (LSE: ARIX) | |
Today | Arix Bioscience (Group) | |
Group | Arix Bioscience (Group) | |
Organisation 2 | Takeda Ventures Inc. (TVI) | |
Group | Takeda (Group) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Person | Anderson, Joe (Sofinnova Partners 2022 Partner before Arix Bioscience + Abingworth) | |
Person 2 | Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) | |
Original document
accessed by [iito] on 2018-10-01
Record changed: 2023-06-05 |
Advertisement
More documents for Arix Bioscience (Group)
- [1] Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA....
- [2] UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels....
- [3] Sorriso Pharmaceuticals, Inc.. (12/22/21). "Press Release: Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions". Salt Lake City, UT....
- [4] Arix Bioscience plc. (12/22/21). "Press Release: Arix Bioscience Co-leads $31 Million Series A Financing for New Portfolio Company Sorriso Pharmaceuticals". London....
- [5] Rentschler Biopharma SE. (9/20/21). "Press Release: Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer, Strengthening Scientific Focus". Laupheim & Milford, MA....
- [6] Pyxis Oncology, Inc.. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA....
- [7] Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London....
- [8] Arix Bioscience plc. (11/5/20). "Press Release: VelosBio to Be Acquired by Merck for $2.75 Billion". London....
- [9] GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris....
- [10] VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top